Annabelle Müller joins Swizzard as Market Access Director
- Michael Zürcher
- May 1
- 2 min read
Swizzard Pharma AG, a solution provider that supports biotech and pharma companies in successfully entering and thriving in the Swiss market, welcomes Annabelle Müller as Market Access Director.
Annabelle has vast experience, including at the Federal Office of Public Health (FOPH) where she served as deputy head in the department responsible for evaluating new candidates for the Specialty List. She will help Swizzard’s clients navigate the Swiss market access landscape and successfully commercialize their products.
Annabelle joins Swizzard from Daiichi-Sankyo (Schweiz) AG, where she was responsible for liaising with the FOPH on matters related to reimbursement for oncology and hematooncology products. A qualified pharmacist, Annabelle has also worked for a health insurer, where her duties included managing article 71a/b/c KVV requests (named patient negotiations) and worked in various roles in the regulatory area, including as a regulatory reviewer at Swissmedic. Her broad experience and background in market access enables Annabelle to provide diverse insights and different stakeholder perspectives.
Annabelle’s experience is enhanced by her commitment to lifelong learning. She recently completed a Master in Pharmaceutical Law (LL.M.) and holds certificates of advanced studies in health economics, applied statistics and social security law. She has strategic planning skills and outstanding knowledge of the Swiss regulatory and market access framework. With excellent writing skills, a sharp analytical mindset and a results-driven approach, Annabelle delivers clear, well-structured insights that drive impactful decision-making.
“Many of Swizzard’s clients are entering the Swiss market for the first time,” says Annabelle Müller. “I’m excited to provide 360° insights to help them bring their breakthrough and tailored products to patients.”
“Annabelle has broad experience, expertise and connections in the regulatory, legal and market access space,” says Michael Zürcher, CEO of Swizzard. “This is sure to be a great asset to Swizzard’s clients – and Swiss patients. We wish her a warm welcome!”
About Swizzard
Swizzard Pharma AG supports biotech and pharma companies in successfully entering and thriving in the Swiss market. Committed to bringing innovation to Switzerland, Swizzard helps clients maximize the value of their medical breakthroughs through expert market entry, preparation, commercialization and access strategies. With deep industry expertise, hands-on experience and an extensive network, Swizzard delivers fast, efficient, and tailored solutions. The company is led by CEO Michael Zürcher, a seasoned life sciences executive with a strong track record in the industry.
コメント